|
|
|
Diagnóstico de la hipertensión arterial
J. Berjón, F. Olaz
Servicio de Cardiología, Hospital de Navarra, Pamplona.
|
|
BIBLIOGRAFÍA 1. Kaplan NM. Systemic hypertension: mechanisms and diagnosis. En: Braunwald E, editor. Heart disease: a textbook of cardiovascular medicine. 5ª edición. Philadelphia: Saunders, 1997: 807-839. 2. The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Arch Intern Med 1997; 157: 2413-2446. 3. National High Blood Pressure Education Program Working Group on Hypertension Control in Children and Adolescents. Update on the 1987 task force report on high blood pressure in children and adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 1996; 98: 649-658. 4. Sinaiko AR. Current concepts: hypertension in children. N Engl J Med 1996; 335: 1968-1973. 5. Consenso para el control de la hipertensión arterial en España. Ministerio de Sanidad y Consumo. Rev Esp Cardiol 1991; 44: 76-94. 6. National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. National High Blood Pressure Education Program working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 1990; 163: 1689-1712. 7. Sibai BM. Treatment of hypertension in pregnant women. N Engl J Med 1996; 335: 257-265. 8. Lindheimer MD. Preeclampsia-eclampsia 1996: preventable? Have disputes on its treatment been resolved? Curr Opin Nephrol Hypertens 1996; 5: 452-458. 9. National High Blood Pressure Education Program Working Group. National High Blood Pressure Education Program working group report on hypertension in the elderly. Hypertension 1994; 23: 275-285. 10. Grossman E, Messerli FH, Grodzicki T, Kowey P. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies? JAMA 1996; 276: 1328-1331. 11. Neaton JD, Wentworth D, for the Multiple Risk Factor Intervention Trial Research Group: Serum cholesterol, blood pressure, cigarette smoking, and death from coronary heart disease: overall finding and differences by age for 316099 white men. Arch Intern Med 1992; 152: 56-64. 12. Burt VL, Whelton P, Roccella EJ et al. Prevalence of hypertension in the US adult population: results from the third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305-313. 13. Wilson PW. Established risk factors and coronary artery disease: The Framingham Study. Am J Hypertens 1994; 7: 7S-12S. 14. Grima A. La ergometría en el diagnóstico y pronóstico de la hipertensión arterial. Rev Esp Cardiol 1995; 48 (Supl 4): 40-44. 15. Zweifler AJ, Shahab ST. Pseudohypertension: A new assessment. J Hypertens 1993; 11: 1-6. 16. Calderón A, Palma JL. La hipertensión de bata blanca en el medio extrahospitalario: indicaciones de la monitorización ambulatoria de la presión arterial (MAPA). Rev Esp Cardiol 1997; 50 (Supl 4): 10-17. 17. Verdecchia P, Schillaci G, Boldrini F, Zampi I, Porcellati C. Variability between current definitions of normal ambulatory blood pressure. Implications in the assessment of white coat hypertension. Hypertension 1992; 20: 555-562. 18. Verdecchia P, Porcellati C, Schillaci G, Bolgioni C. Ambulatory blood pressure. An independent predictor of prognosis in essencial hypertension. Hypertension 1994; 24: 793-801. 19. Julius S, Mejia A, Jones K, Krause L, Sork N, Van de Ven C et al. White coat versus sustained borderline hypertension in Tecumseh, Michigan. Hypertension 1990; 16: 617-623. 20. Perloff D, Grim C, Flack J, Frohlich DE, Hill M, Mcdonald M et al for the Writing Group. Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2467.
|